Dr. Humberto Enrique Trejo Bittar, MD

Dr. Trejo Bittar practices at H Lee Moffitt Cancer Center & Research Institute I - HOPD in Tampa, Florida.

Dr. Trejo Bittar's NPI, 1205221520, was assigned on April 2, 2015. Dr. Trejo Bittar graduated from Central University of Venezuela in 2004. Dr. Trejo Bittar holds Florida license ME153175.

Dr. Trejo Bittar's primary practice is H Lee Moffitt Cancer Center & Research Institute I - HOPD, at 10901 McKinley Dr, Tampa, FL 33612.

Dr. Trejo Bittar's primary practice is H Lee Moffitt Cancer Center & Research Institute I - HOPD in Tampa, Florida. Dr. Trejo Bittar is also affiliated with Moffitt Cancer Hospital. The medical group on file is Moffitt Cancer Center. Dmand AI also links Dr. Trejo Bittar to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Trejo Bittar practices, 4 sites in all. Vendor and product names are available with a free account.

Anatomic pathology is Dr. Trejo Bittar's primary specialty in the NPI Registry, under taxonomy code 207ZP0101X. Dr. Trejo Bittar is board certified in pathology - anatomic by the American Board of Pathology. Dmand AI has Dr. Trejo Bittar's licenses on file in 2 states: Florida and Pennsylvania.

CMS data shows 3,702 Medicare services from Dr. Trejo Bittar across 14 procedure codes in 2024, for 535 Medicare patients. Medicare paid $111,143 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 535 Medicare patients who saw Dr. Trejo Bittar in 2024. The largest group is 65 to 74, with 265 patients. 75% of them have cancer, and 75% have high blood pressure. 4% are also on Medicaid. Their average risk score is 2.00, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Trejo Bittar's median patient age at 71, with 54% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Trejo Bittar for performance year 2024, reported as part of a group. Dr. Trejo Bittar accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 30 papers to Dr. Trejo Bittar, published from 2014 to 2022. 2021 was the busiest year, with 6. The most frequent topics are Lung, Biopsy and Lung Neoplasms. Dr. Trejo Bittar has published most often in Hum Pathol. Dr. Trejo Bittar's most frequent co-authors are Daniel Jeremy Kass, MD, Kristen L. Veraldi and Nitin Agarwal, MD.

CMS Open Payments shows 4 general payments to Dr. Trejo Bittar from 2 drug and device companies from 2021 to 2025. Consulting fees make up the largest share, 96% of the total. Daiichi Sankyo Inc. paid the most, $4,843.

Dr. Trejo Bittar graduated from Central University of Venezuela in 2004.

Dr. Trejo Bittar is in network with 5 carriers, including Excellus BlueCross BlueShield, Amerihealth Caritas and Cigna. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.